¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
competence inducing factor
¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
carcinogenic factor
¹ß¾ÏÀÎÀÚ
corticotropin-releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
chemotactic factor
ÈÇнò¸²ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
cell
¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
chemotactic factor
ÈÇÐÁÖ¼ºÀÎÀÚ, ÈÇнò¸²ÀÎÀÚ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
Àû°ÝÀÎÀÚ
competence inducing factor
Àû°ÝÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
EDRF (endothlium-derived relaxing factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í)
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
Factor IX
IX ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor V
V ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor VII
VII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor VIII
VIII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor X activated
Ȱ¼ºÈ(üÀàõûù)µÈ X ÀÀ°íÀÎÀÚ(ëêͳì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
dark cell norepinephrine cell
¾îµÎ¿î¼¼Æ÷ ³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷
interstitial cell dark cell
»çÀÌÁú¼¼Æ÷
interstitial cell leydigs cell
»çÀÌÁú¼¼Æ÷
lupus erythematosus cell = LE cell
È«¹Ý¼º ·çǪ½º¼¼Æ÷(¡á¬øà)
neurolemmal cell [schwanns cell]
½Å°æÁý¼¼Æ÷
pale cell acanthoma => clear cell acanthoma
parafollicular cell [calcitonin cell]
¼ÒÆ÷°ç¼¼Æ÷
plasma cell orificial mucositis => plasma cell cheilitis
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
secretory epithelial cell [glandular cell]
ºÐºñ»óÇǼ¼Æ÷ (»ù¼¼Æ÷)
supporting cell [sertoli cell]
¹öÆÀ¼¼Æ÷
supporting cell [type ii glomus cell]
¹öÆÀ¼¼Æ÷
sustentacular cell [sertoli cell]
¹öÆÀ¼¼Æ÷
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
age factor
¿¬·ÉÀÎÀÚ.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½